Table 1 (abstract P15). Outcome measures
Parameter | Erenumab 140 mg | Placebo |
|---|---|---|
ETT | ||
 Peak SBP | 172.1 (22.9) | 172.2 (22.4) |
 Peak DBP | 90.1 (15.1) | 90.3 (15.4) |
 Peak heart rate | 122.2 (19.7) | 122.6 (22.0) |
Post-ETT | ||
 SBP | 134.5 (15.2) | 135.0 (18.5) |
 DBP | 76.2 (9.3) | 79.2 (11.6) |
 Heart rate | 73.3 (8.7) | 78.8 (13.7) |